Provided by Tiger Fintech (Singapore) Pte. Ltd.

Precision Drilling

54.90
+0.38000.70%
Post-market: 54.900.00000.00%16:36 EDT
Volume:56.58K
Turnover:3.10M
Market Cap:729.56M
PE:10.52
High:55.39
Open:55.07
Low:54.22
Close:54.52
52wk High:75.19
52wk Low:36.20
Shares:13.29M
Float Shares:12.63M
Volume Ratio:0.74
T/O Rate:0.45%
Dividend:0.00
Dividend Rate:0.00%
EPS(TTM):5.22
EPS(LYR):5.43
ROE:6.40%
ROA:4.45%
PB:0.60
PE(LYR):10.11

Loading ...

PDS Biotechnology Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 28

PDS Biotechnology FY 2024 GAAP EPS $(1.03) Beats $(1.11) Estimate

Benzinga
·
Mar 27

Press Release: PDS Biotech Reports Full Year 2024 Financial Results and Provides Clinical Programs Update

Dow Jones
·
Mar 27

Precision Drilling Corporation 2025 First Quarter Results Conference Call and Webcast

GlobeNewswire
·
Mar 27

REX (REX) Beats Q4 Earnings and Revenue Estimates

Zacks
·
Mar 26

PDS Biotech Leadership to Present at 2025 CAGLA NeauxCancer Conference

GlobeNewswire
·
Mar 25

Precision Drilling (PDS) Gets a Buy from RBC Capital

TIPRANKS
·
Mar 25

PDS Biotechnology (PDSB): Among the Penny Stocks With Huge Upside Potential According to Analysts

Insider Monkey
·
Mar 23

PDS Invests in New Associate Company for Apparel Design and Manufacturing

MT Newswires Live
·
Mar 19

PDS Biotech Announces Conference Call and Webcast for Full Year 2024 Financial Results

GlobeNewswire
·
Mar 18

PDS Biotechnology Price Target Maintained With a $21.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 14

Analysts Offer Insights on Healthcare Companies: PDS Biotechnology (PDSB) and Cartesian Therapeutics (RNAC)

TIPRANKS
·
Mar 14

PDS Biotechnology Receives FDA Clearance for Versamune MUC1 Trial in Colon Cancer

MT Newswires Live
·
Mar 13

PDS Biotech Announces FDA Clearance of IND Application for Combination of Versamune® MUC1 and PDS01ADC to Treat Metastatic Colorectal Cancer

GlobeNewswire
·
Mar 13

PDS Biotech Leadership to Participate in March Conferences

GlobeNewswire
·
Mar 11

Precision Drilling Corporation Announces Filing of Annual Disclosure Documents

GlobeNewswire
·
Mar 11

Precision Drilling Highlights 2024 Achievements and Market Position

TIPRANKS
·
Mar 11

PDS Biotechnology Price Target Maintained With a $21.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 08

PDS Biotechnology’s Promising Phase 3 Trial and Strong Clinical Foundation Justify Buy Rating

TIPRANKS
·
Mar 07

PDS Biotechnology initiates VERSATILE-003 Phase 3 trial of Versamune HPV

TIPRANKS
·
Mar 07